Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Applicability of cholesterol-lowering primary prevention trials to a general population: the framingham heart study.

Lloyd-Jones DM, O'Donnell CJ, D'Agostino RB, Massaro J, Silbershatz H, Wilson PW. Applicability of cholesterol-lowering primary prevention trials to a general population: the framingham heart study. Arch Intern Med. 2001 Apr 09; 161(7):949-54.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.